Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
JAMA Cardiol. 2019 Sep 1;4(9):874-883. doi: 10.1001/jamacardio.2019.2499.
Whether optimal cardiovascular health metrics may counteract the risk of cardiovascular events among patients with prediabetes or diabetes is unclear.
To investigate the associations of ideal cardiovascular health metrics (ICVHMs) with subsequent development of cardiovascular disease (CVD) among participants with prediabetes or diabetes as compared with participants with normal glucose regulation.
DESIGN, SETTING, AND PARTICIPANTS: The China Cardiometabolic Disease and Cancer Cohort Study was a nationwide, population-based, prospective cohort study of 20 communities from various geographic regions in China. The study included 111 765 participants who were free from CVD or cancer at baseline. Data were analyzed between 2011 and 2016.
Prediabetes and diabetes were defined according to the American Diabetes Association 2010 criteria. Seven ICVHMs were adapted from the American Heart Association recommendations.
The composite of incident fatal or nonfatal CVD, including cardiovascular death, myocardial infarction, stroke, and hospitalized or treated heart failure.
Of the 111 765 participants, 24 881 (22.3%) had normal glucose regulation, 61 024 (54.6%) had prediabetes, and 25 860 (23.1%) had diabetes. Mean (SD) age ranged from 52.9 (8.6) years to 59.4 (8.7) years. Compared with participants with normal glucose regulation, among participants with prediabetes, the multivariable-adjusted hazard ratio for CVD was 1.34 (95% CI, 1.16-1.55) for participants who had 1 ICVHM or less and 0.57 (95% CI, 0.43-0.75) for participants who had at least 5 ICVHMs; among participants with diabetes, the hazard ratios for CVD were 2.05 (95% CI, 1.76-2.38) and 0.80 (95% CI, 0.56-1.15) for participants who had 1 ICVHM or less and at least 5 ICVHMs, respectively. Such pattern of association between ICVHMs and CVD was more prominent for participants younger than 55 years (prediabetes and at least 5 ICVHMs: hazard ratio [HR], 0.32; 95% CI, 0.16-0.63; 1 ICVHM or less: HR, 1.58; 95% CI, 1.13-2.21; diabetes and at least 5 ICVHMs: HR, 0.99; 95% CI, 0.44-2.26; 1 ICVHM or less: HR, 2.46; 95% CI, 1.71-3.54; compared with normal glucose regulation) than for participants 65 years or older (prediabetes and at least 5 ICVHMs: HR, 0.80; 95% CI, 0.50-1.26; 1 ICVHM or less: HR, 1.01; 95% CI, 0.79-1.31; diabetes and at least 5 ICVHMs: HR, 0.79; 95% CI, 0.46-1.35; 1 ICVHM or less: HR, 1.73; 95% CI, 1.36-2.22, compared with normal glucose regulation; P values for interaction ≤.02). Additionally, the hazard ratio for CVD per additional ICVHM was 0.82 (95% CI, 0.79-0.86) among participants with prediabetes and was 0.85 (95% CI, 0.80-0.89) among participants with diabetes.
Participants with prediabetes or diabetes who had 5 or more ICVHMs exhibited lower or no significant excess CVD risks compared with the participants with normal glucose regulation.
尚不清楚理想心血管健康指标(ICVHMs)是否可以抵消患有前驱糖尿病或糖尿病患者发生心血管事件的风险。
与血糖正常的参与者相比,比较患有前驱糖尿病或糖尿病的参与者与正常葡萄糖调节参与者之间,理想心血管健康指标(ICVHMs)与随后发生心血管疾病(CVD)之间的关联。
设计、地点和参与者:中国心脏代谢疾病和癌症队列研究是一项全国性的、基于人群的、前瞻性的队列研究,涵盖了中国不同地理区域的 20 个社区。研究纳入了基线时无 CVD 或癌症的 111765 名参与者。数据分析时间为 2011 年至 2016 年。
根据美国糖尿病协会 2010 年的标准,将前驱糖尿病和糖尿病定义为前驱糖尿病和糖尿病。从美国心脏协会的建议中采用了 7 项 ICVHMs。
主要复合终点为致命或非致命性 CVD 的发生,包括心血管死亡、心肌梗死、卒中和住院或治疗性心力衰竭。
在 111765 名参与者中,24881 名(22.3%)血糖正常,61024 名(54.6%)患有前驱糖尿病,25860 名(23.1%)患有糖尿病。平均(SD)年龄范围为 52.9(8.6)岁至 59.4(8.7)岁。与血糖正常的参与者相比,患有前驱糖尿病的参与者中,心血管疾病的多变量调整后风险比为:至少有 5 项 ICVHMs 的参与者为 0.57(95%CI,0.43-0.75),而只有 1 项 ICVHM 或更少的参与者为 1.34(95%CI,1.16-1.55);患有糖尿病的参与者中,心血管疾病的风险比为:至少有 5 项 ICVHMs 的参与者为 0.80(95%CI,0.56-1.15),而只有 1 项 ICVHM 或更少的参与者为 2.05(95%CI,1.76-2.38)。这种 ICVHMs 与 CVD 之间的关联模式在年龄小于 55 岁的参与者中更为明显(前驱糖尿病和至少 5 项 ICVHMs:风险比[HR],0.32;95%CI,0.16-0.63;1 项 ICVHM 或更少:HR,1.58;95%CI,1.13-2.21;糖尿病和至少 5 项 ICVHMs:HR,0.99;95%CI,0.44-2.26;1 项 ICVHM 或更少:HR,2.46;95%CI,1.71-3.54;与血糖正常调节相比),而在 65 岁或以上的参与者中则不那么明显(前驱糖尿病和至少 5 项 ICVHMs:HR,0.80;95%CI,0.50-1.26;1 项 ICVHM 或更少:HR,1.01;95%CI,0.79-1.31;糖尿病和至少 5 项 ICVHMs:HR,0.79;95%CI,0.46-1.35;1 项 ICVHM 或更少:HR,1.73;95%CI,1.36-2.22;与血糖正常调节相比;P 值交互作用均小于 0.02)。此外,患有前驱糖尿病的参与者每增加 1 项 ICVHM,CVD 的风险比为 0.82(95%CI,0.79-0.86),而患有糖尿病的参与者的风险比为 0.85(95%CI,0.80-0.89)。
与血糖正常的参与者相比,患有前驱糖尿病或糖尿病且至少有 5 项 ICVHMs 的参与者发生 CVD 的风险较低或无显著增加。